Well said, DrDazmo! I, too, vividly remember the disappointment at losing Cellestis to the Europeans, after a decade of struggles, testing, and an endless merry-go-round of approval cycles.
Mark Twain said "History doesn't repeat, but it often rhymes"', and that seems to be happening right now with SMN. However, I suspect that our chances of holding on are a little bit stronger in the case of SMN, simply because management had the foresight to develop a profitable arm in the form of AEM.
Obviously, if you need the money, then sell. But it looks to me as if the potential rewards now substantially outweigh the risks. That elusive finishing line of FAA approval really is in sight. Keep your nerve.
Cheers
Past Life, page-2
Add SMN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.010(2.60%) |
Mkt cap ! $51.30M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.0¢ | $17.83K | 47.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
37.0¢ |
Change
-0.010 ( 1.33 %) |
||||
| Open | High | Low | Volume | ||
| 39.0¢ | 39.0¢ | 37.0¢ | 5603 | ||
| Last updated 14.39pm 21/05/2024 ? | |||||
| SMN (ASX) Chart |